199 related articles for article (PubMed ID: 33737833)
1. Prognostic Value of Combined Detection of Preoperative Albumin-to-Fibrinogen Ratio and Neutrophil-to-Lymphocyte Ratio in Operable Esophageal Squamous Cell Carcinoma Patients without Neoadjuvant Therapy.
Zheng Z; Lin D; Chen Q; Zheng B; Liang M; Chen C; Zheng W
Cancer Manag Res; 2021; 13():2359-2370. PubMed ID: 33737833
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the Preoperative Albumin/Fibrinogen Ratio in Patients with Esophageal Squamous Cell Carcinoma after Surgical Resection.
Zhang H; Ren P; Ma M; Zhu X; Zhu K; Xiao W; Gong L; Tang P; Yu Z
J Cancer; 2021; 12(16):5025-5034. PubMed ID: 34234871
[No Abstract] [Full Text] [Related]
3. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
Li S; Zhang D; Zeng S; Wu T; Wang Y; Zhang H; Wang B; Hu X
J Cancer; 2021; 12(19):5864-5873. PubMed ID: 34475999
[No Abstract] [Full Text] [Related]
6. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
7. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of combined preoperative prognostic nutritional index and neutrophil to lymphocyte ratio in esophageal squamous cell carcinoma.
Zhang J; Zhang Y; Yv X; Song M; Zhang F; Tian X; Lv Y
Transl Cancer Res; 2020 Sep; 9(9):5117-5127. PubMed ID: 35117878
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
10. The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
Lv X; Han S; Xu B; Deng Y; Feng Y
BMC Cancer; 2021 Sep; 21(1):1072. PubMed ID: 34592957
[TBL] [Abstract][Full Text] [Related]
11. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
12. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
[TBL] [Abstract][Full Text] [Related]
13. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil-to-lymphocyte ratio in middle thoracic esophageal squamous cell carcinoma patients undergoing radical esophagectomy.
Hu J; Chen D; Wu S; Chen Y; Li R; Miao H; Wen Z
J Thorac Dis; 2020 Mar; 12(3):363-374. PubMed ID: 32274102
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery.
Wang J; Shi H; Fan Z; Yang J; Zheng Y; Zeng D; Zhang J; Hai B
Cancer Med; 2023 Jul; 12(13):14207-14224. PubMed ID: 37199384
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
Shao Y; Ning Z; Chen J; Geng Y; Gu W; Huang J; Pei H; Shen Y; Jiang J
Sci Rep; 2015 Dec; 5():18811. PubMed ID: 26689680
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.
Liu JS; Huang Y; Yang X; Feng JF
Am J Cancer Res; 2015; 5(7):2180-9. PubMed ID: 26328248
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
19. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Kijima T; Arigami T; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Okumura H; Maemura K; Ishigami S; Natsugoe S
Cancer Sci; 2017 Feb; 108(2):193-199. PubMed ID: 27889946
[TBL] [Abstract][Full Text] [Related]
20. Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy.
Zhang H; Guo XW; Yin XX; Liu YC; Ji SJ
Cancer Manag Res; 2019; 11():9459-9468. PubMed ID: 31819611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
